Search


Earlier this month, Agilent agreed to acquire Philadelphia based Proscia, a provider of digital pathology software for clinical and life-sciences customers, for $240M up front and up to $30M more
Co-Founder & CEO David West describes the deal and why Proscia believes Agilent can take the business to a new level, and discusses how AI is changing pathology.
Oct 26


AI x Bio Summit: Proscia CEO David West describes how AI in pathology is not just helping pathologists find disease, but can also help get the right drug to the right patient
He describes how computing power in pathology is augmenting the work that pathologists traditionally do, but also is becoming an...
Jul 24, 2025






.png)
